DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Steppich B, Dobler F, Brendel LC. et al.
Effect of the FXa inhibitors Rivaroxaban and Apixaban on platelet activation in patients with atrial fibrillation.
J Thromb Thrombolysis 2017;
43 (04) 490-497
We do not assume any responsibility for the contents of the web pages of other providers.